< 1 minute read
Sep. 15, 2021

Compound 25: A RORγt oral in vivo allosteric inhibitor

"compound 25"-2

RORγt allosteric inhibitor Orally bioavailable in higher species from HTS and ligand-based design ACS Med. Chem. Lett. 11, 114-119 Merck, Boston, MA

drughunter.com
Drug Hunter Team

RORγt inhibitor from Merck (Merck ROR-gamma-t oral in vivo allosteric inhibitor)

Loading...

twitterlinkedinemail

Other molecules you may be interested in